Background
- Assess severity
- Mild – K+ 5.5-6.0 mmol/L
- Possible emergency – K+ 6.1-6.9 mmol/L
- Usually an emergency – K+ >7.0 mmol/L
- Above needs to be taken into context, if sudden rise with AKI, more likely to be significant
- Symptoms
- Arrhythmias
- Muscle weakness, paraesthesia, fatigue
- ECG changes
- peaked T waves, widening QRS complex
- Causes
- Pseudohyperkalaemia
- contamination from FBC tube, delayed arrival of specimen at lab, storage at low tempreatures, leakage from platelets, difficult sample collection
- Medications
- ACE, ARB
- Potassium supplements
- Potassium sparing diuretics – spironolactone, amiloride
- NSAIDs
- Trimethoprim
- Heparin
- Beta blockers
- AKI/CKD (usually stage 4+)
- Diabetic nephropathy
- Pseudohyperkalaemia
Data gathering
- Red flags – muscle weakness, paralysis, paraesthesia, fatigue
- Others – medications, passing urine
Clinical management
- K+ 5.5 – 5.9
- Repeat K+ within 1-2 weeks
- Review medications, renal function
- Take more seriously if
- sudden decrease in eGFR
- rise > 0.5 mmol/L
- K+ 6.0 – 7.0
- Recheck as soon as possible
- Stop contributing medications
- ECG
- Consider referral to AAU (not A+E) depending on:
- clinical state of patient
- arrhythmia
- muscle weakness, paralysis, paraesthesia, fatigue
- ECG changes
- rapid fall in eGFR
- rapid increase in potassium (>0.5 mmol/L within 2 weeks)
- K+ 7.0
- refer to hospital (avoid A+E unless acutely unwell)